nach oben

Der Schmerz

Erschienen in:

01.06.2008 | CME Weiterbildung • Zertifizierte Fortbildung

Neue Substanzen und Applikationsformen für die postoperative Schmerztherapie

verfasst von: Prof. Dr. E.M. Pogatzki-Zahn, P.K. Zahn

Erschienen in: Der Schmerz | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Entstehung postoperativer Schmerzen beruht auf unterschiedlichen pathophysiologischen Mechanismen und ist abhängig von dem durchgeführten operativen Eingriff. Daher sollte eine erfolgversprechende postoperative Schmerztherapie auf einem prozedurenspezifischen, multimodalen Analgesieregime basieren. Neben der Steigerung des Patientenkomforts und der Senkung perioperativer Komplikationen stellt eine optimale postoperative Schmerztherapie mittlerweile auch ein wichtiges Qualitätsmerkmal dar, das die Auswahl des Krankenhauses durch den Patienten beeinflussen kann. In den letzten 1–2 Jahren wurden für die postoperative Schmerztherapie bekannte Substanzgruppen neu endeckt (z. B. Gabapentin und Pregabalin, i. v. Lidocain, Ketamin oder Glukokortikoide) und neue Substanzen (Coxibe, orales Oxycodon+Naloxon) oder Applikationsverfahren entwickelt. Im vorliegenden Übersichtsartikel sollen die Vor- und Nachteile dieser Substanzen bzw. Analgesieverfahren aufgearbeitet und entsprechende spezifische Anwendungsbereiche diskutiert werden.

Kehlet H (2004) Effect of postoperative pain treatment on outcome-current status and future strategies. Langenbecks Arch Surg 389: 244–249PubMedCrossRef

Kehlet H, Holte K (2001) Effect of postoperative analgesia on surgical outcome. Br J Anaesth 87: 62–72PubMedCrossRef

Simanski C, Lefering R, Paffrath T et al. (2006) Postoperative pain relief is an important factor for the patients‘ selection of a clinic. Results of an anonymous survey. Schmerz 20: 327–333PubMedCrossRef

Kehlet H, Werner M, Perkins F (1999) Balanced analgesia: what is it and what are its advantages in postoperative pain? Drugs 58: 793–797PubMedCrossRef

Kehlet H, Wilmore DW (2002) Multimodal strategies to improve surgical outcome. Am J Surg 183: 630–641PubMedCrossRef

Gajraj NM (2007) Pregabalin: its pharmacology and use in pain management. Anesth Analg 105: 1805–1815PubMed

Dahl JB, Mathiesen O, Moiniche S (2004) ‚Protective premedication’: an option with gabapentin and related drugs? A review of gabapentin and pregabalin in in the treatment of post-operative pain. Acta Anaesthesiol Scand 48: 1130–1136PubMedCrossRef

Ho KY, Gan TJ, Habib AS (2006) Gabapentin and postoperative pain – a systematic review of randomized controlled trials. Pain 126: 91–101PubMedCrossRef

Hurley RW, Cohen SP, Williams KA et al. (2006) The analgesic effects of perioperative gabapentin on postoperative pain: a meta-analysis. Reg Anesth Pain Med 31: 237–247PubMedCrossRef

10.

Seib RK, Paul JE (2006) Preoperative gabapentin for postoperative analgesia: a meta-analysis. Can J Anaesth 53: 461–469PubMed

11.

Tiippana EM, Hamunen K, Kontinen VK, Kalso E (2007) Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg 104: 1545–1556PubMedCrossRef

12.

Buvanendran A, Kroin JS, Kerns JM et al. (2004) Characterization of a new animal model for evaluation of persistent postthoracotomy pain. Anesth Analg 99: 1453–1460PubMedCrossRef

13.

Field MJ, Holloman EF, McCleary S et al. (1997) Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 282: 1242–1246PubMed

14.

Gilron I (2006) Review article: the role of anticonvulsant drugs in postoperative pain management: a bench-to-bedside perspective. Can J Anaesth 53: 562–571PubMed

15.

Kaneko M, Mestre C, Sanchez EH, Hammond DL (2000) Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther 292: 743–751PubMed

16.

Kavoussi R (2006) Pregabalin: from molecule to medicine. Eur Neuropsychopharmacol (Suppl 2) 16: S128–S133

17.

Turan A, Kaya G, Karamanlioglu B et al. (2006) Effect of oral gabapentin on postoperative epidural analgesia. Br J Anaesth 96: 242–246PubMedCrossRef

18.

Dierking G, Duedahl TH, Rasmussen ML et al. (2004) Effects of gabapentin on postoperative morphine consumption and pain after abdominal hysterectomy: a randomized, double-blind trial. Acta Anaesthesiol Scand 48: 322–327PubMedCrossRef

19.

Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q (2002) The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 95: 985–991PubMedCrossRef

20.

Fassoulaki A, Stamatakis E, Petropoulos G et al. (2006) Gabapentin attenuates late but not acute pain after abdominal hysterectomy. Eur J Anaesthesiol 23: 136–141PubMedCrossRef

21.

Kehlet H (2006) Perioperative analgesia to prevent chronic postmastectomy pain. Anesth Analg 103: 494; author reply 494–495PubMedCrossRef

22.

Solak O, Metin M, Esme H et al. (2007) Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain. Eur J Cardiothorac Surg 32: 9–12PubMedCrossRef

23.

Menigaux C, Adam F, Guignard B et al. (2005) Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg 100: 1394–1399; table of contentsPubMedCrossRef

24.

Hill CM, Balkenohl M, Thomas DW et al. (2001) Pregabalin in patients with postoperative dental pain. Eur J Pain 5: 119–124PubMedCrossRef

25.

Reuben SS, Ekman EF, Raghunathan K et al. (2006) The effect of cyclooxygenase-2 inhibition on acute and chronic donor-site pain after spinal-fusion surgery. Reg Anesth Pain Med 31: 6–13PubMedCrossRef

26.

Rose MA, Kam PCA (2002) Gabapentin: pharmacology and its use in pain management. Anaesthesia 57: 451–462PubMedCrossRef

27.

Pandey CK, Navkar DV, Giri PJ et al. (2005) Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: a randomized, double-blind, placebo-controlled study. J Neurosurg Anesthesiol 17: 65–68PubMedCrossRef

28.

Bisgaard T, Klarskov B, Kehlet H, Rosenberg J (2003) Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg 238: 651–660PubMedCrossRef

29.

Karst M, Kegel T, Lukas A (2003) Effect of celecoxib and dexamethasone on postoperative pain after lumbar disc surgery. Neurosurgery 53: 336–337

30.

Afman CE, Welge JA, Steward DL (2006) Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials. Otolaryngol Head Neck Surg 134: 181–186PubMedCrossRef

31.

Romundstad L, Breivik H, Niemi G (2004) Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects. Acta Anaesthesiol Scand 48: 1223–1231PubMedCrossRef

32.

Romundstad L, Breivik H, Roald H (2006) Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo. Anesth Analg 102: 418–425PubMedCrossRef

33.

Fujii Y, Nakayama M (2007) Reduction of postoperative nausea and vomiting and analgesic requirement with dexamethasone in women undergoing general anesthesia for mastectomy. Breast J 13: 564–567PubMedCrossRef

34.

Kjetil H, Sem TK, Ellen S, Johan R (2007) The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (Rofecoxib) before breast surgery. Anesth Analg 105: 481–486PubMedCrossRef

35.

Lee Y, Lai H-Y, Lin P-C et al. (2004) A dose ranging study of dexamethasone for preventing patient-controlled analgesia-related nausea and vomiting: a comparison of droperidol with saline. Anesth Analg 98: 1066–1071PubMedCrossRef

36.

Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA (2000) Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 23: 449–461PubMedCrossRef

37.

Salerno A, Hermann R (2006) Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature. J Bone Joint Surg Am 88: 1361–1372PubMedCrossRef

38.

Romundstad L, Stubhaug A (2007) Glucocorticoids for acute and persistent postoperative neuropathic pain. Anesthesiology 107: 371–373PubMedCrossRef

39.

Dougherty PM, Palacek J, Paleckova V et al. (1992) The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci 12: 3025–3041PubMed

40.

Pogatzki EM, Niemeier JS, Sorkin LS, Brennan TJ (2003) Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision. Pain 105: 97–107PubMedCrossRef

41.

Pogatzki EM, Zahn PK, Brennan TJ (2000) Effect of pretreatment with intrathecal excitatory amino acid receptor antagonists on the development of pain behavior caused by plantar incision. Anesthesiology 93: 489–496PubMedCrossRef

42.

Zahn PK, Pogatzki-Zahn EM, Brennan TJ (2005) Spinal administration of MK-801 and NBQX demonstrates NMDA-independent dorsal horn sensitization in incisional pain. Pain 114: 499–510PubMedCrossRef

43.

Zahn PK, Brennan TJ (1998) Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain. Anesthesiology 88: 143–156PubMedCrossRef

44.

De Kock M, Lavand’homme P, Waterloos H (2001) ‚Balanced analgesia‘ in the perioperative period: Is there a place for ketamine? Pain 92: 373–380CrossRef

45.

Schmid RL, Sandler AN, Katz J (1999) Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain 82: 111–125PubMedCrossRef

46.

Elia N, Tramer MR (2005) Ketamine and postoperative pain–a quantitative systematic review of randomised trials. Pain 113: 61–70PubMedCrossRef

47.

Vranken JH, Troost D, Haan P de et al. (2006) Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine. Anesthesiology 105: 813–818PubMedCrossRef

48.

Errando CL, Sifre C, Moliner S et al. (1999) Subarachnoid ketamine in swine – pathological findings after repeated doses: acute toxicity study. Reg Anesth Pain Med 24: 146–152PubMedCrossRef

49.

Becke K, Höhne C, Jöhr M, Reich A (2007) Stellungnahme Arbeitskreis Kinderanästhesie: S(+)- Ketamin als Supplement zur Kaudalanästhesie im Kindesalter. Anästh Intensivmed 48: 299

50.

Subramaniam K, Subramaniam B, Steinbrook RA (2004) Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 99: 482–495; table of contentsPubMedCrossRef

51.

Vandermeulen E (2006) Systemic analgesia and co-analgesia. Acta Anaesthesiol Belg 57: 113–120PubMed

52.

Duedahl TH, Romsing J, Moiniche S, Dahl JB (2006) A qualtitative systematic review of peri-operative detromethorphan in post-operative pain. Acta Anaesthesiol Scand 50: 1–13PubMedCrossRef

53.

Angst MS, Clark JD (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104: 570–587PubMedCrossRef

54.

Carroll IR, Angst MS, Clark JD (2004) Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 29: 576–591PubMedCrossRef

55.

Koppert W (2005) Opioid-induced analgesia and hyperalgesia. Schmerz 19: 386–390, 392–394PubMedCrossRef

56.

Laulin JP, Maurette P, Corcuff JB et al. (2002) The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 94: 1263–1269PubMedCrossRef

57.

Koppert W, Sittl R, Scheuber K et al. (2003) Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 99: 152–159PubMedCrossRef

58.

Koppert W (2004) Opioid-induced hyperalgesia. Pathophysiology and clinical relevance. Anaesthesist 53: 455–466PubMedCrossRef

59.

Hansen EG, Duedahl TH, Romsing J et al. (2005) Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery. Acta Anaesthesiol Scand 49: 1464–1470PubMed

60.

Weinbroum AA (2003) A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg 96: 789–795PubMedCrossRef

61.

Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367: 1618–1625PubMedCrossRef

62.

Eisenach JC (2006) Preventing chronic pain after surgery: who, how, and when? Reg Anesth Pain Med 31: 1–3PubMedCrossRef

63.

Eisenach JC (2006) Treating and preventing chronic pain: a view from the spinal cord–Bonica Lecture, ASRA Annual Meeting, 2005. Reg Anesth Pain Med 31: 146–151PubMedCrossRef

64.

McCartney CJ, Sinha A, Katz J (2004) A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg 98: 1385–1400; table of contentsPubMedCrossRef

65.

Lavand’homme P (2006) Perioperative pain. Curr Opin Anaesthesiol 19: 556–561CrossRef

66.

Lavand’homme P, De Kock M, Waterloos H (2005) Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery. Anesthesiology 103: 813–820CrossRef

67.

Sinnott CJ, Garfield JM, Strichartz GR (1999) Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat. Pain 80: 521–531PubMedCrossRef

68.

Mao J, Chen LL (2000) Systemic lidocaine for neuropathic pain relief. Pain 87: 7–17PubMedCrossRef

69.

Omana-Zapata I, Khabbaz MA, Hunter JC et al. (1997) Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain 72: 41–49PubMedCrossRef

70.

Devor M, Wall PD, Catalan N (1992) Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 48: 261–268PubMedCrossRef

71.

Lai J, Hunter JC, Porreca F (2003) The role of voltage-gated sodium channels in neuropathic pain. Curr Opin Neurobiol 13: 291–297PubMedCrossRef

72.

Gold MS, Weinreich D, Kim CS et al. (2003) Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci 23: 158–166PubMed

73.

Tremont-Lukats IW, Challapalli V, McNicol ED et al. (2005) Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and Meta-analysis. Anesth Analg 101: 1738–1749PubMedCrossRef

74.

Challapalli V, Tremont-Lukats IW, McNicol ED et al. (2005) Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 4: CD003345PubMed

75.

Cassuto J, Wallin G, Hogstrom S et al. (1985) Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 64: 971–974PubMedCrossRef

76.

Groudine SB, Fisher HA, Kaufman RP Jr et al. (1998) Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg 86: 235–239PubMedCrossRef

77.

Koppert W, Weigand M, Neumann F et al. (2004) Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 98: 1050–1055; table of contentsPubMedCrossRef

78.

Herroeder S, Pecher S, Schönherr ME et al. (2007) Systemic lidocaine shortens length of hospital stay after colorectal surgery. A double-blinded, randomized, placebo-controlled trial. Ann Surg 246: 192–200PubMedCrossRef

79.

Brack A, Bottiger BW, Schafer M (2006) New aspects in postoperative pain therapy. Anasthesiol Intensivmed Notfallmed Schmerzther 41: 184–192PubMedCrossRef

80.

Schäfer M (2008) Postoperative Schmerztherapie – Behandlungsgrundsätze systemischer Schmerztherapie. In: Pogaztki-Zahn EM, Zahn PK (Hrsg) Postoperative Schmerztherapie – Pathophysiologie, Pharmakologie und Therapie. Thieme, Stuttgart, S 70–85

81.

Legeby M, Sandelin K, Wickman M, Olofsson C (2005) Analgesic efficacy of diclofenac in combination with morphine and paracetamol after mastectomy and immediate breast reconstruction. Acta Anaesthesiol Scand 49: 1360–1366PubMedCrossRef

82.

Elia N, Lysakowski C, Tramer MR (2005) Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 103: 1296–1304PubMedCrossRef

83.

Marret E, Kurdi O, Zufferey P, Bonnet F (2005) Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology 102: 1249–1260PubMedCrossRef

84.

Romsing J, Moiniche S, Mathiesen O, Dahl JB (2005) Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation: a systematic review. Acta Anaesthesiol Scand 49: 133–142PubMedCrossRef

85.

Romsing J, Moiniche S (2004) A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 48: 525–546PubMedCrossRef

86.

Garcia Rodriguez LA, Barreales Tolosa L (2007) Risk of upper gastrointestinal complications among users of traditional NSAID and Coxibs in the general population. Gastroenterology 132: 790–794CrossRef

87.

Peura DA, Goldkind L (2005) Balancing the gastrointestinal benefits and risks of nonselective NSAID. Arthritis Res Ther 7: 7–13CrossRef

88.

Nau C, Schüttler J (2008) Klinische Pharmakologie analgetischer Substanzen. In: Pogatzki-Zahn EM, Zahn PK (Hrsg) Postoperative Schmerztherapie – Pathophysiologie, Pharmakologie und Therapie. Thieme, Stuttgart, S 42–69

89.

Laine L (2001) Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120: 594–606PubMedCrossRef

90.

Mamdani M, Rochon PA, Juurlink DN (2002) Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 325: 624PubMedCrossRef

91.

Warner TD, Mitchell JA (2008) COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet 371: 270–273PubMedCrossRef

92.

Whelton A (2006) Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Am J Cardiol 97: 3E–9ECrossRef

93.

Lee A, Cooper MC, Craig JC et al. (2004) Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev 2: CD002765PubMed

94.

Hennekens CH, Borzak S (2008) Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease. J Cardiovasc Pharmacol Ther 13: 41–50PubMedCrossRef

95.

Ott E, Nussmeier NA, Duke PC et al. (2003) Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 125: 1481–1492PubMedCrossRef

96.

Nussmeier NA, Whelton AA, Brown MT et al. (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352: 1081–1091PubMedCrossRef

97.

Nussmeier NA, Whelton AA, Brown MT et al. (2006) Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 104: 518–526PubMedCrossRef

98.

Schug SA, Camu F, Joshi GP, Pan S (2006) Cardiovascular safety of cyclo-oxygenase selective inhibitor parecoxib sodium: review of pooled data from surgical studies. Eur J Anaesthesiol 23: A-849

99.

Joshi GP, Gertler R, Fricker R (2007) Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Anesth Analg 105: 1793–1804; table of contentsPubMed

100.

Prausnitz MR, Mitragotri S, Langer R (2004) Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3: 115–124PubMedCrossRef

101.

Grond S, Hall J, Spacek A et al. (2007) Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management. Br J Anaesth 98: 806–815PubMedCrossRef

102.

Viscusi ER, Reynolds L, Chung F et al. (2004) Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA 291: 1333–1341PubMedCrossRef

103.

Viscusi ER, Siccardi M, Damaraju CV et al. (2007) The safety and efficacy of fentanyl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management: an analysis of pooled data from three randomized, active-controlled clinical studies. Anesth Analg 105: 1428–1436; table of contentsPubMedCrossRef

104.

Viscusi ER, Reynolds L, Tait S et al. (2006) An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. Anesth Analg 102: 188–194PubMedCrossRef

105.

Power I (2007) Fentanyl HCl iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain. Br J Anaesth 98: 4–11PubMedCrossRef

106.

Panchal SJ, Damaraju CV, Nelson WW et al. (2007) System-related events and analgesic gaps during postoperative pain management with the fentanyl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia. Anesth Analg 105: 1437–1441; table of contentsPubMed

107.

Rawal N, Langford RM (2007) Current practices for postoperative pain management in Europe and the potential role of the fentanyl HCl iontophoretic transdermal system. Eur J Anaesthesiol 24: 299–308PubMedCrossRef

108.

Bisgaard T (2006) Analgesic treatment after laparoscopic cholecystectomy: a critical assessment of the evidence. Anesthesiology 104: 835–846PubMedCrossRef

109.

Bisgaard T, Klarskov B, Kristiansen VB et al. (1999) Multi-regional local anesthetic infiltration during laparoscopic cholecystectomy in patients receiving prophylactic multi-modal analgesia: a randomized, double-blinded, placebo-controlled study. Anesth Analg 89: 1017–1024PubMedCrossRef

110.

Liu SS, Richman JM, Thirlby RC, Wu CL (2006) Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualtitative systematic review of randomized controlled trials. J Am Coll Surg 203: 914–932PubMedCrossRef

111.

Lavand’homme P, Roelants F, Waterloos H, De Kock MF (2007) Postoperative analgesic effects of continuous wound infiltration with diclofenac after elective cesarean delivery. Anesthesiology 106: 1220–1225CrossRef

112.

Giesa M, Jage J, Meurer A (2006) Postoperative Schmerztherapie in der Orthopädie und Unfallchirurgie. Orthopade 35: 211–222PubMedCrossRef

113.

Stiehl M (2004) [Controlled release oxycodone–a new option in the treatment of severe and very severe pain. Review of studies on neuropathic, physical activity-related and postoperative pain]. MMW Fortschr Med (Suppl 2) 146: 61–69

114.

Pogatzki-Zahn EM, Zahn PK (2007) Systemic analgesia: an update. Anasthesiol Intensivmed Notfallmed Schmerzther 42: 22–31PubMedCrossRef

115.

Cheville A, Chen A, Oster G et al. (2001) A randomized trial controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am 83: 572–576PubMedCrossRef

116.

Kampe S, Warm M, Kaufmann J et al. (2004) Clinical efficacy of controlled release oxycodone 20 mg administered on a 12-n dosing schedule on the management of postopeative pain after breast surgery for cancer. Curr Med Res Opin 20: 199–202PubMedCrossRef

117.

Kalso E (2005) Oxycodone. J Pain Symptom Manage (Suppl 5) 55: S47–S56CrossRef

118.

Ginsberg B, Sinatra RS, Adler LJ et al. (2003) Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting. Pain Med 4: 31–38PubMedCrossRef

119.

Hopp M, Ruckes C, Friedman M et al. (2005) The combination of naloxone with prolonged release (pr) oxycodone is able to reduce opioid-induced constipation – results of a clinical study. Schmerz (Suppl 1): 103

120.

Müller-Lissner S, Leyendecker P, Hopp M et al. (2007) Oral prolonged release (PR) oxycodone/naloxone combination reduces opioid-induced bowel dysfunction (OIBD) in patients with severe chronic pain. Eur J Pain 11: 82CrossRef

Titel: Neue Substanzen und Applikationsformen für die postoperative Schmerztherapie
verfasst von: Prof. Dr. E.M. Pogatzki-Zahn
P.K. Zahn
Publikationsdatum: 01.06.2008
Verlag: Springer-Verlag
Erschienen in: Der Schmerz / Ausgabe 3/2008
Print ISSN: 0932-433X
Elektronische ISSN: 1432-2129
DOI: https://doi.org/10.1007/s00482-008-0665-5

Neu im Fachgebiet AINS

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Neue Substanzen und Applikationsformen für die postoperative Schmerztherapie

Zusammenfassung

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Fibromyalgiesyndrom

Physiotherapie, medizinische Trainingstherapie und physikalische Therapie beim Fibromyalgiesyndrom

Definition, Klassifikation und Diagnose des Fibromyalgiesyndroms

Ätiopathogenese und Pathophysiologie des Fibromyalgiesyndroms und chronischer Schmerzen in mehreren Körperregionen

Komplementäre und alternative Verfahren beim Fibromyalgiesyndrom

Liebe Kolleginnen, liebe Kollegen

Neu im Fachgebiet AINS

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS